Europa Biosite has announced a new distribution partnership with BellBrook Labs, a US-based developer of innovative biochemical assay technologies and validated enzyme solutions for drug discovery and life science research. The agreement expands access to BellBrook Labs’ portfolio of high-throughput screening (HTS) assays, active enzymes, and specialist assay development solutions for researchers across Europe and North America.
Founded in Madison, Wisconsin, BellBrook Labs has supported pharmaceutical, biotechnology and academic researchers for more than 20 years, helping accelerate enzyme-targeted drug discovery through robust assay technologies and expert enzymology services. Through this partnership, Europa Biosite will provide scientists with access to BellBrook Lab’s proven solutions for generating reliable, reproducible data across a broad range of therapeutic research areas.
BellBrook Lab’s portfolio is centred around its proprietary Transcreener®, AptaFluor®, and Enzolution™ technology platforms, which enable direct detection of nucleotide products and highly sensitive measurement of enzyme activity. These technologies support research involving kinases, ATPases, GTPases, methyltransferases, helicases, DNA damage response targets, innate immune pathways and other challenging enzyme classes. Designed for automated high-throughput screening environments, BellBrook Labs’ solutions help simplify assay workflows, reduce development time and deliver highly consistent results.
Researchers worldwide rely on BellBrook Labs for assay kits, validated recombinant enzymes, substrates, screening reagents and contract research services that support target validation, inhibitor discovery and lead optimisation. The company’s expertise in assay development and enzymology enables customers to advance drug discovery programmes efficiently from early-stage target identification through hit-to-lead screening.
Europa Biosite is recognised for building strong supplier partnerships and delivering innovative technologies to academic, biotechnology, pharmaceutical and clinical research laboratories through its extensive distribution network across Europe and North America. The addition of BellBrook Labs further strengthens Europa Biosite’s offering in the fields of drug discovery, enzymology and high-throughput screening, providing researchers with trusted tools to accelerate therapeutic development.
Partner with Europa Biosite
Europa Biosite partners with life science suppliers who share our values on quality, innovation and service.
If you are looking for a leading European and US distributor partner, we want to hear from you.